300871.SZ
HVSEN Biotechnology Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 22.67
−2.87%Margins
Gross margin
33.7%
EBITDA margin
23.7%
EBIT margin
18.8%
Net margin
16.5%
FCF margin
5.9%
12.7%
Return on equity
8.8%
Return on assets
12.7%
Return on invested capital
0.56x
Asset turnover
CNY 233.1M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026